Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Hypoxia × Radiotherapy × Clear all

Phase

Status

Unknown 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 6 Breast Neoplasms 6 Small Cell Lung Carcinoma 5 Rectal Neoplasms 5 Neoplasms 4 Glioblastoma 4 Esophageal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Uterine Cervical Neoplasms 3 Prostatic Neoplasms 3 Non-Muscle Invasive Bladder Neoplasms 3 Nasopharyngeal Carcinoma 3 Brain Neoplasms 3 Urinary Bladder Neoplasms 2 Triple Negative Breast Neoplasms 2 Neoplasm Metastasis 2 Esophageal Squamous Cell Carcinoma 2 Colorectal Neoplasms 2 Carcinoma 2 Stomach Neoplasms 1 Small Cell Lung Cancer Extensive Stage 1 Sarcoma 1 Rhabdomyosarcoma 1 Recurrence 1 Rectal Cancer Patients 1 Radiotherapy-induced Oral Mucositis 1 Radiation Injuries 1 Pelvic Neoplasms 1 Oropharyngeal Neoplasms 1 NSCLC 1

Interventions

fludarabine 1 Temozolomide 1 Radiotherapy 1 Injections 1 Cyclophosphamide 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06477939 2024-06-27

THREE-GLEES

Institut de cancérologie Strasbourg Europe

Phase 3 Not yet recruiting

Hypoxia, Brain Neoplasms, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡